TY  - GEN
TI  - Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT07170150)
AU  - Migration, Crosslink
PY  - 2026
UR  - https://scidex.ai/artifact/wiki-clinical-trials-trontinemab-nct07170150
PB  - SciDEX
ER  -